[Indapamide SR/Amlodipine Fixed Dose Combination: Novel Approach to Effective Control of Systolic Arterial Pressure]

Area of Science:

• Cardiology
• Pharmacology

Background:

• Effective control of arterial pressure (AP) is achieved in only one-third of hypertension patients.
• Systolic AP (SAP) control is particularly difficult in elderly patients, where it's a strong predictor of cardiovascular events.
• High arterial stiffness, common in the elderly, contributes to elevated SAP and pulse pressure (PAP).

Purpose of the Study:

• To evaluate the efficacy and safety of a fixed-dose combination of indapamide-retard and amlodipine for managing arterial hypertension.
• To explore this combination as an alternative treatment for patients with difficult-to-control hypertension, particularly those with high SAP and PAP.

Main Methods:

• The study reviews existing evidence on the efficacy and safety profiles of indapamide-retard and amlodipine.
• It assesses the potential benefits of combining these two antihypertensive agents in a fixed-dose preparation.

Main Results:

• Both indapamide-retard (a thiazide-like diuretic) and amlodipine (a calcium antagonist) are effective in lowering elevated SAP and PAP.
• Their combination is supported by modern hypertension management guidelines but was previously limited by the lack of a fixed preparation.
• The fixed indapamide-retard/amlodipine combination presents a new therapeutic option.

Conclusions:

• A fixed combination of indapamide-retard and amlodipine offers a new perspective for effective arterial hypertension therapy.
• This combination is particularly suitable for elderly patients and others with high arterial stiffness and elevated SAP and PAP.
• It addresses the need for convenient and effective treatment options in managing challenging hypertension cases.